JMI LABS IS NOW PART OF LEARN MORE

In Vitro Activity of Ceftazidime/NXL104 Against Pathogens Collected During a Phase II Complicated Urinary Tract infection (cUTI) Clinical Trial, Lead author: Sader HS, presented at 51st annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 17 – 20, 2011, Chicago, IL

View publication